Vera Therapeutics, Inc. (VERA)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-26) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-05) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-05) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-26) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | 8-K (2024-10-28) · 99.1 · 99.2 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-20) · 99.1 | 8-K (2024-01-29) | ||
| 10-Q | Q3-2023 | 8-K (2023-11-09) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-10) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | — |
|
| Document and Entity Information | — |
|
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations and Comprehensive Loss | ||
| Statements of Stockholders' Equity | ||
| Statements of Cash Flows | ||
| Notes | ||
| Basis of Presentation and Significant Accounting Policies | — |
|
| Cash Equivalents and Marketable Securities | ||
| Cash, Cash Equivalents and Marketable Securities | — |
|
| Cash, Cash Equivalents, and Marketable Securities | — |
|
| Commitments and Contingencies | ||
| Common Stock | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Employee Benefit Plans | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Licenses | — |
|
| Licenses and Collaborations | ||
| Net Loss Per Share Attributable To Common Stockholders | ||
| Non-marketable Equity Securities | ||
| Note Payable | ||
| Organization and Description of The Business | ||
| Other Financial Statement Information | ||
| Pay Vs Performance Disclosure | ||
| Related Party Transactions | ||
| Segment Reporting | ||
| Stock Compensation | ||
| Stockholders' Equity | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | — |
|